# FDA Inspection 918374 - Suzhou Lixin Pharmaceutical Co. Ltd. - March 13, 2015

Source: https://www.keypedia.com/records/fda_inspections/suzhou-lixin-pharmaceutical-co-ltd/a81073ff-6e55-4d96-b8a2-e60f24bc98fb
Source feed: FDA_Inspections

> FDA Inspection 918374 for Suzhou Lixin Pharmaceutical Co. Ltd. on March 13, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 918374
- Company Name: Suzhou Lixin Pharmaceutical Co. Ltd.
- Inspection Date: 2015-03-13
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1259886 - 2023-08-30](https://www.keypedia.com/records/fda_inspections/suzhou-lixin-pharmaceutical-co-ltd/774fa5a0-216c-4fc9-9bf3-04eb43b7a985)

Company: https://www.keypedia.com/companies/suzhou-lixin-pharmaceutical-co-ltd/2ad0b1cc-f2ce-4670-9844-bde1417dd946

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c